Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: SLM003
MIFTS: 55

Salmonellosis

Categories: Immune diseases, Infectious diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Salmonellosis

About this section

MalaCards integrated aliases for Salmonellosis:

Name: Salmonellosis 12 76 3 15 73
Salmonella Infections 55 43 73
Salmonella Infection 12 15

Classifications:

MalaCards categories:
Global: Infectious diseases
Anatomical: Immune diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:0060859
ICD10 33 A02.0 A02.8
ICD9CM 35 003.0
Sources

Summaries for Salmonellosis

About this section
MedlinePlus : 43 Salmonella is the name of a group of bacteria. In the United States, it is a common cause of foodborne illness. Salmonella occurs in raw poultry, eggs, beef, and sometimes on unwashed fruit and vegetables. You also can get infected after handling pets, especially reptiles like snakes, turtles, and lizards. Symptoms include Fever Diarrhea Abdominal cramps Headache Possible nausea, vomiting, and loss of appetite Symptoms usually last 4-7 days. Your health care provider diagnoses the infection with a stool test. Most people get better without treatment. Infection can be more serious in the elderly, infants, and people with chronic health problems. If Salmonella gets into the bloodstream, it can be serious. The usual treatment is antibiotics. Typhoid fever, a more serious disease caused by Salmonella, is not common in the United States. It frequently occurs in developing countries. NIH: National Institute of Allergy and Infectious Diseases

MalaCards based summary : Salmonellosis, also known as salmonella infections, is related to typhoid fever and schistosomiasis, and has symptoms including fever and pruritus. An important gene associated with Salmonellosis is IL12RB1 (Interleukin 12 Receptor Subunit Beta 1), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Azithromycin and Cefixime have been mentioned in the context of this disorder. Affiliated tissues include testes, colon and liver, and related phenotypes are Increased viability and hematopoietic system

Disease Ontology : 12 A primary bacterial infectious disease caused by the bacteria of the genus Salmonella. It has sypmtoms diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. In most cases, the illness lasts four to seven days, and most people recover without treatment.

CDC : 3 CDC estimates Salmonella causes about 1.2 million illnesses, 23,000 hospitalizations, and 450 deaths in the United States every year. Food is the source for about 1 million of these illnesses.

Wikipedia : 76 Salmonellosis is a symptomatic infection caused by bacteria of the Salmonella type. The most common... more...

Sources

Related Diseases for Salmonellosis

About this section

Diseases related to Salmonellosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 224)
# Related Disease Score Top Affiliating Genes
1 typhoid fever 31.7 ALB CASP1 IFNG IFNGR1 IL1B SLC11A1
2 schistosomiasis 30.2 ALB IFNG IFNGR1
3 pneumonia 30.1 IL1B LACTB TLR4
4 osteomyelitis 30.1 IFNG IFNGR1 IL1B
5 campylobacteriosis 29.9 IFNG IL1B JUN SLC11A1 STAT1 TLR4
6 meningitis 29.8 ALB IFNG IL1B LACTB
7 viral infectious disease 29.8 IFNG IL1B STAT1
8 chagas disease 29.8 IFNG IL1B TLR4
9 pyelonephritis 29.7 ALB IL1B TLR4
10 acquired immunodeficiency syndrome 29.7 ALB IFNG IL1B
11 gastroenteritis 29.7 ALB IL1B LACTB
12 cysticercosis 29.7 IL18 IL1B TLR4
13 systemic lupus erythematosus 29.6 ALB IFNG IL18 IL1B STAT1 TLR4
14 fascioliasis 29.6 ALB CP IFNG IL1B
15 brucellosis 29.5 IFNG IL18 SLC11A1 TLR4
16 lymphadenitis 29.2 IFNG IFNGR1 IL12RB1 IL18 IL1B SLC11A1
17 malaria 28.9 ALB CASP1 IFNG IFNGR1 IL18 IL1B
18 inflammatory bowel disease 28.0 ALB CASP1 DEFB1 DEFB4A IFNG IFNGR1
19 invasive non-typhoidal salmonellosis 12.2
20 immunodeficiency 30 11.4
21 immunodeficiency 27b 11.2
22 immunodeficiency 29 11.2
23 immunodeficiency 27a 11.1
24 shigellosis 10.5
25 interferon gamma, receptor 1, deficiency 10.3 IFNG IFNGR1
26 axillary adenitis 10.3 IL12RB1 STAT1
27 mycobacterium fortuitum 10.2 IFNGR1 IL12RB1 LACTB
28 prosthetic joint infection 10.2 IL1B TLR4
29 macs syndrome 10.2 IFNGR1 IL12RB1 SLC11A1
30 variola major 10.2 IFNG TLR4
31 staphylococcal toxic shock syndrome 10.2 IFNG IL1B
32 coccidioidomycosis 10.2 IFNGR1 STAT1 TLR4
33 bacterial pneumonia 10.2 DEFB4A LACTB TLR4
34 q fever 10.2 IFNG IL1B TLR4
35 bacterial vaginosis 10.2 DEFB4A IL1B TLR4
36 cutaneous leishmaniasis 10.2 IFNG SLC11A1 TLR4
37 eumycotic mycetoma 10.2 DEFB4A IFNG IL1B
38 gastritis 10.2 DEFB1 DEFB4A IL1B
39 toxic shock syndrome 10.2 IFNG IL1B TLR4
40 meningitis and encephalitis 10.2 ALB CP
41 toxoplasmosis 10.2 IFNG IL1B TLR4
42 listeriosis 10.2
43 abdominal tuberculosis 10.1 ALB IL12RB1
44 testicular disease 10.1 ALB IFNG SLC11A1
45 filariasis 10.1 ALB IFNG TLR4
46 helicobacter pylori infection 10.1 IFNGR1 IL1B JUN
47 leprosy 3 10.1 ALB IFNG SLC11A1
48 upper respiratory tract disease 10.1 ALB IFNG IL1B
49 lupus erythematosus 10.1
50 eales disease 10.1 CP IFNG IL1B

Comorbidity relations with Salmonellosis via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Salmonellosis:



Diseases related to Salmonellosis
Sources

Symptoms & Phenotypes for Salmonellosis

About this section

UMLS symptoms related to Salmonellosis:


fever, pruritus

GenomeRNAi Phenotypes related to Salmonellosis according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased viability GR00386-A-1 9.36 ALB CASP1 DEFB1 IL18 IL1B JUN

MGI Mouse Phenotypes related to Salmonellosis:

46 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.3 CASP1 CP IFNG IFNGR1 IL12RB1 IL18
2 cellular MP:0005384 10.29 ALB CASP1 CP IFNG IFNGR1 IL18
3 homeostasis/metabolism MP:0005376 10.25 ALB CASP1 CP IFNG IFNGR1 IL12RB1
4 immune system MP:0005387 10.25 CASP1 CP IFNG IFNGR1 IL12RB1 IL18
5 cardiovascular system MP:0005385 10.22 CASP1 CP IFNG IFNGR1 IL18 IL1B
6 digestive/alimentary MP:0005381 10.15 ALB CASP1 IFNG IFNGR1 IL18 SLC11A1
7 endocrine/exocrine gland MP:0005379 10.08 ALB CASP1 IFNG IFNGR1 JUN SPI1
8 mortality/aging MP:0010768 10.03 ALB CASP1 IFNG IFNGR1 IL18 IL1B
9 integument MP:0010771 10.02 CASP1 IFNG IFNGR1 IL18 IL1B JUN
10 liver/biliary system MP:0005370 9.92 ALB CP IFNG IFNGR1 JUN SPI1
11 neoplasm MP:0002006 9.81 ALB CASP1 IFNG IFNGR1 IL1B SLC11A1
12 nervous system MP:0003631 9.7 CASP1 CP IFNG IFNGR1 IL18 IL1B
13 skeleton MP:0005390 9.28 IFNG IFNGR1 IL1B JUN NLRC4 SPI1
Sources

Drugs & Therapeutics for Salmonellosis

About this section

Drugs for Salmonellosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 46)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4 83905-01-5 55185 447043
2
Cefixime Approved, Investigational Phase 4 79350-37-1 5362065 54362
3
Ceftriaxone Approved Phase 4,Not Applicable 73384-59-5 5479530 5361919
4
Gatifloxacin Approved, Investigational Phase 4 112811-59-3 5379
5 Antibiotics, Antitubercular Phase 4
6 Anti-Bacterial Agents Phase 4,Not Applicable
7 Anti-Infective Agents Phase 4,Phase 1,Phase 2,Not Applicable
8 Antitubercular Agents Phase 4
9 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
10 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
11 Topoisomerase Inhibitors Phase 4
12 Fluoroquinolones Phase 4
13 Nucleic Acid Synthesis Inhibitors Phase 4
14
Lactitol Investigational Phase 3,Phase 2 585-86-4 3871
15
Zinc Approved, Investigational Phase 1, Phase 2 7440-66-6
16
Albendazole Approved, Vet_approved Phase 1, Phase 2 54965-21-8 2082
17
Secnidazole Approved Phase 1, Phase 2 3366-95-8
18
Zinc sulfate Approved, Investigational Phase 1, Phase 2 7733-02-0
19
Metronidazole Approved Phase 1, Phase 2 443-48-1 4173
20
Formaldehyde Approved, Vet_approved Phase 2 50-00-0 712
21
Vitamin A Approved, Nutraceutical, Vet_approved Phase 2 11103-57-4, 68-26-8 445354
22 Heptavalent Pneumococcal Conjugate Vaccine Phase 2
23 Pharmaceutical Solutions Phase 1, Phase 2,Phase 2,Not Applicable
24 Trace Elements Phase 1, Phase 2
25 Micronutrients Phase 1, Phase 2
26 Antiparasitic Agents Phase 1, Phase 2
27 Antimitotic Agents Phase 1, Phase 2
28 Astringents Phase 1, Phase 2
29 Antiprotozoal Agents Phase 1, Phase 2
30 Anthelmintics Phase 1, Phase 2
31 Dermatologic Agents Phase 1, Phase 2
32 Retinol palmitate Phase 2
33 Immunoglobulins Phase 2,Not Applicable
34 Antibodies Phase 2,Not Applicable
35 retinol Phase 2
36
Pectin Approved, Investigational, Vet_approved Phase 1 9000-69-5 441476
37
Loperamide Approved Phase 1 53179-11-6 3955
38 Antidiarrheals Phase 1
39 Gastrointestinal Agents Phase 1
40
Amoxicillin Approved, Vet_approved Not Applicable 26787-78-0 33613
41
Ampicillin Approved, Vet_approved Not Applicable 69-53-4 6249
42
Infliximab Approved 170277-31-3
43 Antirheumatic Agents
44 Immunosuppressive Agents
45 Disinfectants
46 Ether

Interventional clinical trials:

(show all 46)
# Name Status NCT ID Phase Drugs
1 Typhoid Fever: Combined vs. Single Antibiotic Therapy Unknown status NCT02224040 Phase 4 ceftriaxone;ceftriaxone and azithromycin;azithromycin;azithromycin and cefixime
2 Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood Completed NCT00125047 Phase 4
3 Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China Completed NCT00131833 Phase 4
4 Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam Completed NCT00131820 Phase 4
5 Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever Completed NCT01421693 Phase 4 Ceftriaxone;Gatifloxacin
6 Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever Completed NCT00125008 Phase 4
7 CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera Recruiting NCT03705585 Phase 4 Vivotif Typhoid Oral Vaccine;Vaxchora
8 Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort Enrolling by invitation NCT03312699 Phase 4
9 Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects Completed NCT01608815 Phase 3
10 A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Completed NCT01466387 Phase 3
11 Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi Active, not recruiting NCT03299426 Phase 3
12 Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults Completed NCT01438996 Phase 2
13 Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants Completed NCT01437267 Phase 2
14 Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants Completed NCT01229176 Phase 2
15 Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old) Completed NCT01193907 Phase 2
16 Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults Completed NCT00679172 Phase 2
17 TY800 Dose Escalation (Typhoid) Completed NCT00269295 Phase 1, Phase 2 Placebo
18 Studies of Immune Responses to Orally Administered Vaccines in Developing Country Completed NCT01019083 Phase 1, Phase 2 Placebo;Placebo;Zinc Sulphate;Albendazole and Secnidazole
19 Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects Completed NCT00498654 Phase 2
20 Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants Completed NCT00342628 Phase 2
21 Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso Recruiting NCT03614533 Phase 2
22 Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine Active, not recruiting NCT03527355 Phase 2
23 Vaccines Against Salmonella Typhi Active, not recruiting NCT02324751 Phase 2
24 Understanding Typhoid Disease After Vaccination Active, not recruiting NCT01405521 Phase 2
25 Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine Completed NCT02645032 Phase 1
26 Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old) Completed NCT01123941 Phase 1
27 CVD 909 Vi Prime Boost Study Completed NCT00326443 Phase 1 Placebo
28 Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine Completed NCT00277147 Phase 1 BB IND 6989
29 Cellular Immune Responses in Typhoid Fever Patients and Vaccinees Recruiting NCT03600025 Phase 1
30 Reservoir of Invasive Salmonellosis in Children, DRC Completed NCT03073707
31 Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients Completed NCT00002052 Not Applicable Ceftriaxone sodium;Ampicillin sodium;Amoxicillin trihydrate
32 NCCLS Interpretive Criteria for Salmonella Completed NCT00177658
33 European Safety Registry in Ulcerative Colitis (P04808) Completed NCT00705484 Standard Therapy
34 Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders Completed NCT02105714
35 Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers Completed NCT02628054 Not Applicable
36 Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers Completed NCT02391909
37 Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age Completed NCT00386789
38 Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035) Completed NCT00705614
39 Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) Completed NCT01766830 Not Applicable
40 Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission Recruiting NCT03494101
41 Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India Recruiting NCT03554213
42 Global Genomic and Proteomic Profiling of African Children With Typhoid Fever Recruiting NCT02947295
43 IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres Active, not recruiting NCT02689193
44 Investigating Typhoid Fever Pathogenesis Active, not recruiting NCT03067961 Not Applicable
45 Understanding Paratyphoid Infection Active, not recruiting NCT02100397 Not Applicable
46 Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study Active, not recruiting NCT02192008 Not Applicable

Search NIH Clinical Center for Salmonellosis

Inferred drug relations via UMLS 73 / NDF-RT 51 :
Sources

Genetic Tests for Salmonellosis

About this section
Sources

Anatomical Context for Salmonellosis

About this section

MalaCards organs/tissues related to Salmonellosis:

41
Testes, Colon, Liver, T Cells, Thyroid, Lung, Kidney
Sources

Publications for Salmonellosis

About this section

Articles related to Salmonellosis:

(show top 50) (show all 1431)
# Title Authors Year
1
Potent O-antigen-deficient (rough) mutants of Salmonella Typhimurium secreting Lawsonia intracellularis antigens enhance immunogenicity and provide single-immunization protection against proliferative enteropathy and salmonellosis in a murine model. ( 29976253 )
2018
2
Municipal Wastewater as a Microbial Surveillance Platform for Enteric Diseases: A Case Study for Salmonella and Salmonellosis. ( 29630348 )
2018
3
Incubation period for outbreak-associated, non-typhoidal salmonellosis cases, Minnesota, 2000-2015. ( 29409557 )
2018
4
Diagnosis and Treatment of Human Salmonellosis in Addis Ababa City, Ethiopia. ( 29951540 )
2018
5
International Symposium on Salmonella and salmonellosis. ( 29366459 )
2018
6
Novel Salmonella enterica Serovar Typhimurium Genotype Levels as Herald of Seasonal Salmonellosis Epidemics. ( 29774859 )
2018
7
Climate variability and salmonellosis in Singapore - A time series analysis. ( 29929293 )
2018
8
Campylobacteriosis, Salmonellosis, Yersiniosis, and Listeriosis as Zoonotic Foodborne Diseases: A Review. ( 29701663 )
2018
9
A Quantitative Risk Assessment of Human Salmonellosis from Consumption of Pistachios in the United States. ( 29757010 )
2018
10
Risk Assessment of Salmonellosis from Consumption of Alfalfa Sprouts and Evaluation of the Public Health Impact of Sprout Seed Treatment and Spent Irrigation Water Testing. ( 29341180 )
2018
11
<i>Salmonella</i> and salmonellosis in horses: an overview. ( 29884637 )
2018
12
Chicken Liver-Associated Outbreaks of Campylobacteriosis and Salmonellosis, United States, 2000-2016: Identifying Opportunities for Prevention. ( 30192164 )
2018
13
In trauma, expect the unexpected: a rare case of post-traumatic pancreatitis associated with salmonellosis and enterocolitis. ( 30413451 )
2018
14
Epidemiology and antimicrobial resistance of invasive non-typhoidal Salmonellosis in rural Thailand from 2006-2014. ( 30080897 )
2018
15
Looking for new approaches for the use of serology in the context of control programmes against pig salmonellosis. ( 29218859 )
2018
16
Burden of intestinal pathogens and associated factors among asymptomatic food handlers in South Ethiopia: emphasis on salmonellosis. ( 30041687 )
2018
17
Global Trends in Typhoidal Salmonellosis: A Systematic Review. ( 30047364 )
2018
18
A Novel Homozygous Mutation With Different Clinical Presentations in 2 IRAK-4-Deficient Siblings: First Case With Recurrent Salmonellosis and Non-Hodgkin Lymphoma. ( 30073964 )
2018
19
Quantitative Microbial Risk Assessment of Salmonellosis from the Consumption of Australian Pork: Minced Meat from Retail to Burgers Prepared and Consumed at Home. ( 30144103 )
2018
20
Genetic diversity and antimicrobial resistance of Salmonella serotypes recovered throughout the beef production chain and from patients with salmonellosis. ( 30155367 )
2018
21
Incubation period of typhoidal salmonellosis: a systematic review and meta-analysis of outbreaks and experimental studies occurring over the last century. ( 30261843 )
2018
22
Laboratory capacity of Greek hospitals for diagnosis of salmonellosis and surveillance systems' performance in the years of economic crisis, 2010-2016. ( 30264684 )
2018
23
Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis. ( 30385055 )
2018
24
Salmonellosis in sheep. ( 30389878 )
2018
25
The role of domestic reservoirs in domestically acquired Salmonella infections in Norway: epidemiology of salmonellosis, 2000-2015, and results of a national prospective case-control study, 2010-2012. ( 30428947 )
2018
26
Risk Assessment for Salmonellosis in Chicken in South Korea: The Effect of Salmonella Concentration in Chicken at Retail. ( 30479510 )
2018
27
Forecasting the incidence of salmonellosis in seniors in Canada: A trend analysis and the potential impact of the demographic shift. ( 30481213 )
2018
28
Short-term and long-term effects of pathogen reduction interventions on salmonellosis from whole chickens. ( 30510752 )
2018
29
Vaccines for preventing invasive salmonella infections in people with sickle cell disease. ( 30521695 )
2018
30
Severe, non specific symptoms in non-typhoidal Salmonella infections in adult patients with sickle cell disease: a retrospective multicentre study. ( 30317897 )
2018
31
An Attenuated Salmonella enterica Serovar Typhimurium Strain and Galacto-Oligosaccharides Accelerate Clearance of Salmonella Infections in Poultry through Modifications to the Gut Microbiome. ( 29269490 )
2018
32
Flea market finds and global exports: Four multistate outbreaks of human Salmonella infections linked to small turtles, United States-2015. ( 29577654 )
2018
33
Health Outcomes from Multidrug-Resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis. ( 29624414 )
2018
34
DO ALL PATIENTS WITH SALMONELLA INFECTIONS REQUIRE A 'PET' SCAN? ( 29867278 )
2018
35
Plasmid-mediated quinolone resistance in human non-typhoidal Salmonella infections: An emerging public health problem in the United States. ( 30027554 )
2018
36
The global burden and epidemiology of invasive non-typhoidal Salmonella infections. ( 30081708 )
2018
37
Preventing Human Salmonella Infections Resulting from Live Poultry Contact through Interventions at Retail Stores. ( 30223636 )
2018
38
Restaurant Inspection Letter Grades and Salmonella Infections, New York, New York, USA. ( 30457518 )
2018
39
A Quantitative Assessment of the Risk of Human Salmonellosis Arising from the Consumption of Pecans in the United States. ( 28812908 )
2017
40
Using Microsimulation to Estimate the Future Health and Economic Costs of Salmonellosis under Climate Change in Central Queensland, Australia. ( 29233795 )
2017
41
Highly suspected cases of salmonellosis in two cats fed with a commercial raw meat-based diet: health risks to animals and zoonotic implications. ( 28738871 )
2017
42
Risk of Salmonellosis from Chicken Parts Prepared from Whole Chickens Sold in Flow Pack Wrappers and Subjected to Temperature Abuse. ( 28800246 )
2017
43
Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020. ( 28935025 )
2017
44
Importation of travel-related infectious diseases is increasing in South Korea: An analysis of salmonellosis, shigellosis, malaria, and dengue surveillance data. ( 28919170 )
2017
45
Impact of Clinical Salmonellosis in Veal Calves on the Recovery of Salmonella in Lymph Nodes at Harvest. ( 28910140 )
2017
46
CXCR3 plays a critical role for host protection against Salmonellosis. ( 28860493 )
2017
47
CASE SERIES: CLINICAL SALMONELLOSIS IN FOUR BLACK RHINOCEROS (DICEROS BICORNIS) CALVES. ( 28749277 )
2017
48
Review of egg-related salmonellosis and reduction strategies in United States, Australia, United Kingdom and New Zealand. ( 28903617 )
2017
49
Immune-Stimulatory and Therapeutic Activity of<i>Tinospora cordifolia</i>: Double-Edged Sword against Salmonellosis. ( 29318160 )
2017
50
Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice. ( 28702137 )
2017
Sources

Variations for Salmonellosis

About this section
Sources

Expression for Salmonellosis

About this section
Search GEO for disease gene expression data for Salmonellosis.
Sources

Pathways for Salmonellosis

About this section

Pathways related to Salmonellosis according to GeneCards Suite gene sharing:

(show top 50) (show all 61)
# Super pathways Score Top Affiliating Genes
1
Innate Immune System 66
Show member pathways
 14.02 CASP1 DEFB1 DEFB4A IFNG IFNGR1 IL12RB1
2
PEDF Induced Signaling 64
Show member pathways
 13.67 CASP1 IFNG IFNGR1 IL12RB1 IL18 IL1B
3
Cytokine Signaling in Immune system 66
Show member pathways
 13.36 CASP1 IFNG IFNGR1 IL12RB1 IL18 IL1B
4
IL-2 Pathway 64
Show member pathways
 13.19 IFNG IFNGR1 IL1B JUN STAT1 TLR4
5
Toll-like Receptor Signaling Pathway 37 1
Show member pathways
 12.98 CASP1 IFNG IFNGR1 IL18 IL1B JUN
6
Allograft rejection 1 37
Show member pathways
 12.89 IFNG IFNGR1 IL12RB1 IL18 IL1B STAT1
7
Pathways in cancer 37
12.84 IFNG IFNGR1 IL12RB1 JUN SPI1 STAT1
8
Influenza A 37
Show member pathways
 12.8 CASP1 IFNG IFNGR1 IL18 IL1B JUN
9
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways 66
Show member pathways
 12.76 CASP1 IFNG IL18 IL1B TLR4
10
4-1BB Pathway 64
Show member pathways
 12.69 IFNG IFNGR1 IL1B JUN STAT1
11
Immune response NFAT in immune response 22
Show member pathways
 12.64 IFNG IFNGR1 IL12RB1 IL18 JUN
12
Immune response IL-23 signaling pathway 22
Show member pathways
 12.61 IFNG IL12RB1 IL18 IL1B STAT1
13
NF-kappaB Signaling 4
12.54 IFNG IL1B SPI1 STAT1
14
Th17 cell differentiation 37
Show member pathways
 12.46 IFNG IFNGR1 IL12RB1 IL18 IL1B JUN
15
JAK-STAT signaling pathway (KEGG) 37
Show member pathways
 12.39 IFNG IFNGR1 IL12RB1 STAT1
16
IL-17 Family Signaling Pathways 65
Show member pathways
 12.34 DEFB4A IFNG IL1B JUN
17
Toxoplasmosis 37
Show member pathways
 12.3 IFNG IFNGR1 IL1B JUN STAT1 TLR4
18
Toll Comparative Pathway 64
Show member pathways
 12.27 IFNG IFNGR1 IL1B JUN SPI1 STAT1
19
IL-1 Family Signaling Pathways 65
Show member pathways
 12.26 CP IL18 IL1B JUN STAT1
20
Necroptosis 37
Show member pathways
 12.24 CASP1 IFNG IFNGR1 IL1B STAT1 TLR4
21
C-type lectin receptor signaling pathway 37
Show member pathways
 12.23 CASP1 IL1B JUN STAT1
22
Colorectal Cancer Metastasis 64
12.2 IFNG IFNGR1 STAT1 TLR4
23
Immune response IFN gamma signaling pathway 22
Show member pathways
 12.11 CASP1 IFNG IFNGR1 IL18 IL1B JUN
24
Direct p53 effectors 1
12.09 CASP1 JUN NLRC4 VDR
25
MAPK Pathway 72
Show member pathways
 12.05 IL1B JUN STAT1 TLR4
26
Tuberculosis 37
12.05 IFNG IFNGR1 IL18 IL1B STAT1 TLR4
27
Osteoclast differentiation 37
12.04 IFNG IFNGR1 IL1B JUN SPI1 STAT1
28
Interleukin-4 and 13 signaling 66
11.96 IL18 IL1B STAT1
29
IL12-mediated signaling events 1
Show member pathways
 11.93 IFNG IL12RB1 IL18 IL1B JUN STAT1
30
Senescence and Autophagy in Cancer 1
11.92 IFNG IL1B JUN
31
Rheumatoid arthritis 37
11.92 IFNG IL18 IL1B JUN TLR4
32
Bacterial infections in CF airways 22
Show member pathways
 11.92 DEFB4A IFNG IFNGR1 IL1B JUN STAT1
33
Jak-Stat Signaling Pathway (sino) 67
11.91 IFNG IFNGR1 IL12RB1 STAT1
34
HIF-1 signaling pathway 37
11.89 IFNG IFNGR1 TLR4
35
AGE-RAGE signaling pathway in diabetic complications 37
11.89 IL1B JUN STAT1
36
Amoebiasis 37
11.87 IFNG IL1B TLR4
37
Glucocorticoid receptor regulatory network 1
11.84 IFNG JUN SPI1 STAT1
38
Innate Lymphoid Cell Differentiation Pathways 65
11.84 IFNG IL12RB1 IL18 IL1B SPI1
39
Pertussis 37
11.8 CASP1 IL1B JUN TLR4
40
Dendritic Cells Developmental Lineage Pathway 65
11.75 IFNG IL1B SPI1
41
Microglia Activation During Neuroinflammation: Microglia Polarization 65
11.73 IFNG IL18 IL1B
42
Photodynamic therapy-induced NF-kB survival signaling 1
Show member pathways
 11.67 IFNG IL1B JUN
43
Th1 Differentiation Pathway 65
Show member pathways
 11.67 IFNG IFNGR1 IL12RB1 IL18 IL1B JUN
44
TGF-beta Receptor Signaling (WikiPathways) 1
11.63 IFNG JUN STAT1
45
Legionellosis 37
11.63 CASP1 IL18 IL1B NLRC4 TLR4
46
Malaria 37
11.6 IFNG IL18 IL1B TLR4
47
MSP-RON Signaling 64
11.58 IFNG IL18 IL1B TLR4
48
Cellular Transformation by HTLV1 64
Show member pathways
 11.57 IFNG IFNGR1 JUN
49
Transcription_Role of VDR in regulation of genes involved in osteoporosis 22
11.55 IFNG IL1B JUN VDR
50
Aryl Hydrocarbon Receptor Pathway 1
11.54 IFNG IL1B JUN
Sources

GO Terms for Salmonellosis

About this section

Cellular components related to Salmonellosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 IPAF inflammasome complex GO:0072557 8.62 CASP1 NLRC4

Biological processes related to Salmonellosis according to GeneCards Suite gene sharing:

(show all 35)
# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.93 IL18 IL1B NLRC4 SLC11A1 TLR4
2 response to lipopolysaccharide GO:0032496 9.85 IL1B JUN SLC11A1 TLR4
3 defense response to bacterium GO:0042742 9.85 DEFB1 DEFB4A NLRC4 SLC11A1 TLR4
4 response to bacterium GO:0009617 9.84 DEFB1 SLC11A1 TLR4
5 cellular response to mechanical stimulus GO:0071260 9.81 CASP1 IL1B TLR4
6 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.81 IL18 IL1B NLRC4 TLR4
7 positive regulation of gene expression GO:0010628 9.8 IFNG IL18 IL1B SLC11A1 TLR4 VDR
8 cellular response to organic cyclic compound GO:0071407 9.79 IL18 IL1B STAT1
9 interferon-gamma-mediated signaling pathway GO:0060333 9.79 IFNG IFNGR1 STAT1
10 positive regulation of smooth muscle cell proliferation GO:0048661 9.77 IL18 JUN STAT1
11 antimicrobial humoral response GO:0019730 9.75 DEFB1 DEFB4A SLC11A1
12 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.74 IL18 IL1B TLR4
13 cellular response to interferon-gamma GO:0071346 9.73 CASP1 IL12RB1 STAT1 TLR4
14 positive regulation of nitric oxide biosynthetic process GO:0045429 9.7 IFNG IL1B TLR4
15 defense response to Gram-negative bacterium GO:0050829 9.67 DEFB1 DEFB4A SLC11A1 TLR4
16 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.66 IFNG IL1B
17 positive regulation of nitric-oxide synthase biosynthetic process GO:0051770 9.66 STAT1 TLR4
18 positive regulation of interferon-alpha production GO:0032727 9.65 STAT1 TLR4
19 interferon-gamma production GO:0032609 9.65 IL18 TLR4
20 negative regulation of interleukin-17 production GO:0032700 9.65 IFNG TLR4
21 lipopolysaccharide-mediated signaling pathway GO:0031663 9.65 IL18 IL1B TLR4
22 macrophage activation GO:0042116 9.64 SLC11A1 TLR4
23 positive regulation of granulocyte macrophage colony-stimulating factor production GO:0032725 9.64 IL18 IL1B
24 positive regulation of T-helper 1 type immune response GO:0002827 9.63 IL12RB1 SLC11A1
25 cytokine-mediated signaling pathway GO:0019221 9.63 CASP1 IFNGR1 IL12RB1 IL18 IL1B STAT1
26 T-helper 1 type immune response GO:0042088 9.62 IL18 TLR4
27 interleukin-1 beta secretion GO:0050702 9.61 NLRC4 TLR4
28 interleukin-6 production GO:0032635 9.6 IL18 IL1B
29 positive regulation of neuroinflammatory response GO:0150078 9.58 IL18 IL1B
30 positive regulation of T-helper 1 cell cytokine production GO:2000556 9.56 IL18 IL1B
31 immune response GO:0006955 9.5 DEFB1 DEFB4A IFNG IL18 IL1B SLC11A1
32 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.49 IFNG IL1B
33 regulation of interferon-gamma-mediated signaling pathway GO:0060334 9.43 IFNG IFNGR1 STAT1
34 positive regulation of interferon-gamma production GO:0032729 9.02 IL12RB1 IL18 IL1B SLC11A1 TLR4
35 positive regulation of transcription by RNA polymerase II GO:0045944 10.01 IL18 IL1B JUN SLC11A1 SPI1 STAT1

Molecular functions related to Salmonellosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.23 ALB CASP1 DEFB1 JUN LACTB NLRC4
2 CCR6 chemokine receptor binding GO:0031731 9.16 DEFB1 DEFB4A
3 transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000982 9.13 JUN SPI1 STAT1
Sources

Sources for Salmonellosis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....